Agios Pharmaceuticals
AGIO
#4802
Rank
HK$16.80 B
Marketcap
HK$282.65
Share price
-3.51%
Change (1 day)
-9.21%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: HK$16.80 Billion

As of July 2026 Agios Pharmaceuticals has a market cap of HK$16.80 Billion. This makes Agios Pharmaceuticals the world's 4802th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$16.80 B32.22%
2025HK$12.71 B-14.03%
2024HK$14.78 B52.12%
2023HK$9.72 B-19.36%
2022HK$12.05 B-13.4%
2021HK$13.91 B-40.17%
2020HK$23.26 B-8.54%
2019HK$25.43 B21%
2018HK$21.02 B-3.47%
2017HK$21.77 B60.17%
2016HK$13.59 B-28.32%
2015HK$18.96 B-41.17%
2014HK$32.24 B456.39%
2013HK$5.79 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Agios Pharmaceuticals was reported to be:

HK$17.42 Billion
by Nasdaq info icon info icon
HK$17.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.109 T 6,498.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$8.131 T 48,273.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$797.08 B 4,641.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
HK$11.34 B-32.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$108.35 B 544.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$88.50 B 426.50%๐Ÿ‡บ๐Ÿ‡ธ USA